Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; Gleevec) in chronic-phase chronic myelogenous leukemia

Hagop M. Kantarjian, Moshe Talpaz, Jorge Cortes, Susan O'Brien, Stefan Faderl, Deborah Thomas, Francis Giles, Mary Beth Rios, Jianqin Shan, Ralph Arlinghaus

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Quantitative polymerase chain reaction monitoring of BCR-ABL during therapy with imatinib mesylate (STI571; Gleevec) in chronic-phase chronic myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences